ATE167662T1 - Verfahren zur herstellung eines lignan-derivats - Google Patents

Verfahren zur herstellung eines lignan-derivats

Info

Publication number
ATE167662T1
ATE167662T1 AT94912092T AT94912092T ATE167662T1 AT E167662 T1 ATE167662 T1 AT E167662T1 AT 94912092 T AT94912092 T AT 94912092T AT 94912092 T AT94912092 T AT 94912092T AT E167662 T1 ATE167662 T1 AT E167662T1
Authority
AT
Austria
Prior art keywords
compound
general formula
producing
lower alkyl
cycloalkyl
Prior art date
Application number
AT94912092T
Other languages
German (de)
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE167662T1 publication Critical patent/ATE167662T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
AT94912092T 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats ATE167662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
ATE167662T1 true ATE167662T1 (de) 1998-07-15

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912092T ATE167662T1 (de) 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats

Country Status (13)

Country Link
US (1) US5488134A (oth)
EP (1) EP0646570B1 (oth)
JP (1) JP3411036B2 (oth)
KR (1) KR100277242B1 (oth)
CN (1) CN1046937C (oth)
AT (1) ATE167662T1 (oth)
AU (1) AU666819B2 (oth)
CA (1) CA2138264C (oth)
DE (1) DE69411243T2 (oth)
DK (1) DK0646570T3 (oth)
ES (1) ES2119190T3 (oth)
TW (1) TW255886B (oth)
WO (1) WO1994024087A1 (oth)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
WO1999016770A1 (en) 1997-09-29 1999-04-08 Meiji Seika Kaisha, Ltd. Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
EP1140185B1 (en) 1998-12-23 2003-06-04 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
PT1140184E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com derivados de acido nicotinico para indicacoes cardiovasculares
NZ512534A (en) 1998-12-23 2003-11-28 G Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
DK1140190T3 (da) 1998-12-23 2002-12-23 Searle Llc Kombinationer af ileumgaldesyretransport-inhibitorer og galdesyre-sekvestreringsmidler til cardiovaskulære indikatorer
ES2200588T3 (es) 1998-12-23 2004-03-01 G.D. Searle Llc Combinacion de inhibidores del transporte de oxido biliar ileal y de derivados de acido fibrico para indicaciones cardiovasculares.
PL348508A1 (en) 1998-12-23 2002-05-20 Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
WO2000038722A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
WO2001068637A2 (en) 2000-03-10 2001-09-20 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
AU2001247331A1 (en) * 2000-03-10 2001-09-24 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
US6852753B2 (en) 2002-01-17 2005-02-08 Pharmacia Corporation Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
BR112014010228B1 (pt) 2011-10-28 2020-09-29 Lumena Pharmaceuticals Llc Uso de inibidores de reciclagem de ácido biliar para o tratamento de hipercolemia e doença hepática colestática
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
RU2015139731A (ru) 2013-03-15 2017-04-20 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи Ингибиторы рециркуляции желчных кислот для лечения первичного склерозирующего холангита и воспалительного заболевания кишечника
US20140271734A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
BR112021015815A2 (pt) 2019-02-12 2022-01-18 Mirum Pharmaceuticals Inc Métodos para tratar colestase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
KR100252428B1 (ko) * 1991-10-17 2000-04-15 시오노 요시히코 리그난유사체,이의제조방법및이를함유한항지혈증제

Also Published As

Publication number Publication date
KR100277242B1 (ko) 2001-02-01
US5488134A (en) 1996-01-30
ES2119190T3 (es) 1998-10-01
DK0646570T3 (da) 1998-10-26
KR950701902A (ko) 1995-05-17
CN1046937C (zh) 1999-12-01
CA2138264A1 (en) 1994-10-27
AU666819B2 (en) 1996-02-22
TW255886B (oth) 1995-09-01
JP3411036B2 (ja) 2003-05-26
AU6437994A (en) 1994-11-08
EP0646570A1 (en) 1995-04-05
EP0646570B1 (en) 1998-06-24
DE69411243D1 (de) 1998-07-30
EP0646570A4 (en) 1995-08-09
CA2138264C (en) 2004-04-06
DE69411243T2 (de) 1998-11-19
CN1109685A (zh) 1995-10-04
WO1994024087A1 (fr) 1994-10-27

Similar Documents

Publication Publication Date Title
DE69411243D1 (de) Verfahren zur herstellung eines lignan-derivats
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69304309D1 (de) Verfahren zur herstellung von taxan-derivaten
ATE186721T1 (de) Vitamin d3 derivat und verfahren zu dessen herstellung
DE69319764D1 (de) Verfahren zur Herstellung von Beta-Lactamderivaten und Zwischenprodukt für ihre Synthese
DE69707341D1 (de) Verfahren zur Herstellung von 4-Aryl-3-Hydroxymethyl-piperidinen
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
ATE131169T1 (de) 2-pyranon-derivat und verfahren zu dessen herstellung.
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
DE69427978D1 (de) Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates
DE69530229D1 (de) Verfahren zur herstellung von 1,5-pentandiol-derivaten
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
ATE131483T1 (de) Verfahren zur herstellung von penemen
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS
ATE277064T1 (de) Verfahren zur herstellung von vinylpyrimidinderivaten
FI915109A0 (fi) Foerfarande foer framstaellning av alifatisk amid och salter daerav.
ATE157357T1 (de) Verfahren zur herstellung von dihydrofuranonderivaten
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür
DE69132547D1 (de) Verfahren zur herstellung von azacycloalkanderivaten
ATE92029T1 (de) Verfahren zur herstellung von 2-cyclohexenylcarboxylaten.
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee